Postdoctoral Researcher
with
Postdoctoral Researcher
Past Lab Member
(
2008
-
2011
)
Dates: January 2008-December 2011
Current Position: Professor of Neurobiochemistry at Macquarie University
Academic Director of the Parkinson's research centre and Macquarie Brain Institute and Clinic
Publications Generated While in the Lab:
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
Deng X, Dzamko N, Prescott A, Davies P, Liu Q, Yang Q, Lee JD, Patricelli MP, Nomanbhoy TK, Alessi DR, Gray NS
Nat Chem Biol. 2011 Apr;7(4):203-5
LRRK2 mutations, regulation and 14-3-3 protein interaction: Implications for Parkinsons disease
Dzamko N, Alessi DR
Future Neurology. Volume 6, Issue 1, January 2011, Pages 5-8
Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization
Dzamko N, Deak M, Hentati F, Reith AD, Prescott AR, Alessi DR, Nichols RJ
Biochem J. 2010 Sep 15;430(3):405-13
14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
Nichols RJ, Dzamko N, Morrice NA, Campbell DG, Deak M, Ordureau A, Macartney T, Tong Y, Shen J, Prescott AR, Alessi DR
Biochem J. 2010 Sep 15;430(3):393-404
Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease
Nichols RJ, Dzamko N, Hutti JE, Cantley LC, Deak M, Moran J, Bamborough P, Reith AD, Alessi DR
Biochem J. 2009 Oct 23;424(1):47-60
Publications Generated While in the Lab:
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
Deng X, Dzamko N, Prescott A, Davies P, Liu Q, Yang Q, Lee JD, Patricelli MP, Nomanbhoy TK, Alessi DR, Gray NS
Nat Chem Biol. 2011 Apr;7(4):203-5
LRRK2 mutations, regulation and 14-3-3 protein interaction: Implications for Parkinsons disease
Dzamko N, Alessi DR
Future Neurology. Volume 6, Issue 1, January 2011, Pages 5-8
Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization
Dzamko N, Deak M, Hentati F, Reith AD, Prescott AR, Alessi DR, Nichols RJ
Biochem J. 2010 Sep 15;430(3):405-13
14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
Nichols RJ, Dzamko N, Morrice NA, Campbell DG, Deak M, Ordureau A, Macartney T, Tong Y, Shen J, Prescott AR, Alessi DR
Biochem J. 2010 Sep 15;430(3):393-404
Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease
Nichols RJ, Dzamko N, Hutti JE, Cantley LC, Deak M, Moran J, Bamborough P, Reith AD, Alessi DR
Biochem J. 2009 Oct 23;424(1):47-60
Country of Origin:

Australia
Contact
Nic
Dzamko
:
